Clinical trial
Prospective Evaluation of Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy in Adult Patients
NCT05083338 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective Evaluation of Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative Chemotherapy in Adult Patients
- Lead sponsor
- M.D. Anderson Cancer Center
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 10, 2021
- Completion date
- February 9, 2024
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
appendix carcinoma, carcinomatosis, colorectal carcinoma, gastric carcinoma, malignant peritoneal neoplasm, malignant solid neoplasm